Saudi Arabia vs Sub-Saharan Africa (IDA & IBRD countries): Access to anti-retroviral drugs, male
Saudi Arabia
93.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
79.8%
in 2024
Saudi Arabia rank
7th
Sub-Saharan Africa (IDA & IBRD countries) rank
7th
Access to anti-retroviral drugs, male over time
- Saudi Arabia
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Saudi Arabia currently reports 93.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 13.2%.
That makes Saudi Arabia's figure about 1.2 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 7th and Sub-Saharan Africa (IDA & IBRD countries) ranks 7th of 141 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.0% | 5.7% | 21.3% | Saudi Arabia |
| 2010s | 56.4% | 42.2% | 14.2% | Saudi Arabia |
| 2020s | 91.2% | 73.2% | 18.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Saudi Arabia or Sub-Saharan Africa (IDA & IBRD countries)?
- Saudi Arabia, at 93.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Saudi Arabia and Sub-Saharan Africa (IDA & IBRD countries)?
- 13.2%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Sub-Saharan Africa (IDA & IBRD countries)?
- 25 years are reported by both, from 2000 to 2024.
- How do Saudi Arabia and Sub-Saharan Africa (IDA & IBRD countries) rank globally for access to anti-retroviral drugs, male?
- Saudi Arabia ranks 7th and Sub-Saharan Africa (IDA & IBRD countries) ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.